Aileron AI
Advanced-therapy commercialization, orchestrated.
Fewer than 50 therapies approved. 4,000+ in development.
Cell & gene therapies are personal, time-critical and high-stakes — and the stakeholders that bring them to patients are buried in portal sprawl, siloed data and manual coordination. Aileron AI connects institutions, manufacturers and labs, cold-chain logistics, wholesalers and HUBs, and payers into one AI-driven mesh — so the right therapy reaches the right patient, on time, with a complete chain of identity at every step.
Built for regulated, high-stakes delivery.
One intelligent login
Ends portal and API sprawl — every stakeholder works from a single connected platform instead of a dozen disconnected ones.
Integrated scheduling
A time-zone-aware calendar coordinates apheresis, manufacturing and infusion across sites and partners.
Multi-site patient tracking
Track patients across multiple sites and therapies, with a complete, tamper-proof chain of identity.
Real-time dashboards
Live visibility into product availability, movement and custody across the network.
Secure & compliant
HIPAA- and GDPR-compliant; AES-256 encryption with blockchain immutability protects PHI and genomic data.
Sovereign, regulator-ready data
Records stay owner-controlled and auditable end to end — ready for regulated therapy delivery.
A tamper-proof thread from apheresis to infusion.
One AI-driven mesh connecting institutions, manufacturers, cold chain and payers — with a regulator-ready audit trail.
